CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,621,299 | +16.1% | 621,138 | +38.0% | 0.79% | +11.2% |
| Q2 2023 | $4,842,000 | -5.3% | 450,000 | -10.0% | 0.71% | -6.4% |
| Q1 2023 | $5,115,000 | -40.1% | 500,000 | -38.2% | 0.76% | -38.5% |
| Q4 2022 | $8,537,387 | +6.7% | 809,231 | +29.7% | 1.24% | +26.4% |
| Q3 2022 | $8,000,000 | +2.4% | 624,016 | +2.4% | 0.98% | -17.2% |
| Q2 2022 | $7,810,000 | – | 609,231 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |